Franklin Resources Inc. Trims Stake in Veeva Systems Inc. $VEEV

Franklin Resources Inc. trimmed its holdings in shares of Veeva Systems Inc. (NYSE:VEEV) by 62.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 646,517 shares of the technology company’s stock after selling 1,082,919 shares during the quarter. Franklin Resources Inc.’s holdings in Veeva Systems were worth $144,322,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. Sivia Capital Partners LLC lifted its holdings in shares of Veeva Systems by 225.9% in the 2nd quarter. Sivia Capital Partners LLC now owns 3,122 shares of the technology company’s stock worth $899,000 after acquiring an additional 2,164 shares during the last quarter. Bank of Nova Scotia raised its position in Veeva Systems by 44.5% in the 2nd quarter. Bank of Nova Scotia now owns 5,866 shares of the technology company’s stock worth $1,689,000 after purchasing an additional 1,806 shares during the period. NewEdge Advisors LLC lifted its stake in Veeva Systems by 34.6% in the second quarter. NewEdge Advisors LLC now owns 8,832 shares of the technology company’s stock worth $2,543,000 after purchasing an additional 2,272 shares during the last quarter. Treasurer of the State of North Carolina lifted its stake in Veeva Systems by 2.2% in the second quarter. Treasurer of the State of North Carolina now owns 68,950 shares of the technology company’s stock worth $19,856,000 after purchasing an additional 1,452 shares during the last quarter. Finally, Diversify Wealth Management LLC boosted its position in Veeva Systems by 5.3% during the second quarter. Diversify Wealth Management LLC now owns 11,399 shares of the technology company’s stock valued at $3,140,000 after buying an additional 575 shares during the period. 88.20% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other news, Director Priscilla Hung sold 750 shares of the stock in a transaction that occurred on Thursday, April 30th. The stock was sold at an average price of $155.64, for a total value of $116,730.00. Following the completion of the transaction, the director owned 3,253 shares of the company’s stock, valued at approximately $506,296.92. This represents a 18.74% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 10.60% of the company’s stock.

Analyst Upgrades and Downgrades

VEEV has been the subject of several recent research reports. Wells Fargo & Company boosted their price objective on Veeva Systems from $317.00 to $320.00 and gave the company an “overweight” rating in a research report on Thursday, June 4th. TD Cowen reiterated a “buy” rating on shares of Veeva Systems in a research report on Thursday, June 4th. Stifel Nicolaus lowered their price objective on Veeva Systems from $245.00 to $230.00 and set a “buy” rating for the company in a research report on Thursday, June 4th. Wall Street Zen downgraded Veeva Systems from a “buy” rating to a “hold” rating in a research report on Sunday, March 22nd. Finally, JPMorgan Chase & Co. lowered their price objective on Veeva Systems from $330.00 to $296.00 and set an “overweight” rating for the company in a research report on Friday, February 20th. Eighteen investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $250.96.

Key Veeva Systems News

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: UCB is unifying global safety operations on Veeva Safety Suite, a sign of continued customer adoption for Veeva’s regulated-industry software platform. UCB Unifies Global Pharmacovigilance Operations with Veeva Safety Suite
• Positive Sentiment: Analysts highlighted Veeva’s strong Q1, growing Vault CRM migrations, and AI expansion as reasons the stock may deserve a place in portfolios. Reasons to Add Veeva Systems Stock to Your Portfolio for Now
• Positive Sentiment: Management’s product push, including Falcon and Vault AI, is improving workflow automation across life sciences and supporting the long-term growth narrative. Veeva’s Falcon and Vault AI: When Could AI Become a Revenue Driver?
• Neutral Sentiment: Recent commentary from Veeva’s earnings call pointed to broad-based customer demand and stronger execution, but also said AI revenue is not expected to be a major contributor in fiscal 2027. The 5 Most Interesting Analyst Questions From Veeva Systems’s Q1 Earnings Call
• Negative Sentiment: Investors are also weighing concerns about saturation in the life sciences CRM market and the fact that AI monetization may take longer to show up in results. Reasons to Add Veeva Systems Stock to Your Portfolio for Now

Veeva Systems Price Performance

VEEV opened at $163.82 on Thursday. The business has a 50 day simple moving average of $165.61 and a two-hundred day simple moving average of $192.92. The firm has a market capitalization of $26.76 billion, a price-to-earnings ratio of 29.20, a PEG ratio of 0.73 and a beta of 0.95. Veeva Systems Inc. has a one year low of $148.05 and a one year high of $310.50.

Veeva Systems (NYSE:VEEV) last issued its quarterly earnings data on Wednesday, June 3rd. The technology company reported $2.24 EPS for the quarter, topping the consensus estimate of $2.14 by $0.10. Veeva Systems had a net margin of 28.37% and a return on equity of 13.72%. The business had revenue of $882.95 million during the quarter, compared to analyst estimates of $857.73 million. During the same period last year, the business posted $1.97 earnings per share. Veeva Systems’s quarterly revenue was up 16.3% compared to the same quarter last year. Veeva Systems has set its FY 2027 guidance at 9.050-9.050 EPS and its Q2 2027 guidance at 2.210-2.220 EPS. As a group, sell-side analysts expect that Veeva Systems Inc. will post 6.55 EPS for the current fiscal year.

Veeva Systems Company Profile

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.